[THE INVESTOR] Kolmar BNH will tackle the overseas market in earnest next year, said Hana Financial Investment on Dec. 26, maintaining a “buy” recommendation and 40,000 won (US$37.14) target price.
Its revenue next year will increase 17 percent from this year to 480.0 billion won and operating profit 18 percent to 57.0 billion won, on the back of over 30 percent sure in exports of health supplements and cosmetics, forecast analyst Park Jong-dae.
Atomy has been expanding its overseas market to 11 countries and exports will account for up to 24 percent, from this year’s 16 percent, of its revenue, according to the analyst.
When the Chinese operation of Atomy wins sales approval in mainland China and completes a jointly established manufacturing facility for food, the improvement will accelerate, said Park.
Recent stock price decline has no relation to its fundamentals, added the analyst advising investors to purchase its stocks at a low price.
By Hwang You-mee (firstname.lastname@example.org)